Inverse correlation between body mass index and clinical outcomes in men with advanced castration-recurrent prostate cancer.
- Citation:
- Cancer vol 110 (7) 1478-84
- Year:
- 2007
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Meta-Analysis
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- CA 36601
- Corr. Author:
- Authors:
- Susan Halabi San-San Ou Nicholas J Vogelzang Eric J Small
- Networks:
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-9181, CALGB-9182, CALGB-90004, CALGB-90006, CALGB-9583, CALGB-9680, CALGB-9780, CALGB-99813
- Phases:
- 2, 3
- Keywords:
- African Americans, Aged, Androgen Antagonists, Antineoplastic Agents, Hormonal, Body Mass Index, Clinical Trials as Topic, Disease-Free Survival, European Continental Ancestry Group, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Multivariate Analysis, Neoplasm Recurrence, Local, Obesity, Predictive Value of Tests, Prospective Studies, Prostate-Specific Antigen, Prostatic Neoplasms, Severity of Illness Index, Testosterone, United States